NCT00311662 - Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions

Migraine Without AuraMigraine With Aura

Interventions

DRUG

Tonabersat

Tablet 40mg daily for 12 weeks

DRUG

Placebo

Tablet once daily for 12 weeks

Trial Locations (17)

Glostrup 2600

Glostrup Amtssygehus, Neurologisk Ambulatorium N01, Copenhagen

Kobenhavn NV 2400

Bispebjerg Hospital, Neurolgisk Afdeling N, Copenhagen

Debrecen 1145

Kenézy Gyula County Hospital, Dept of Neurology, Debrecen

Gyor 9024

Petz Aladár Megyei Oktató Kórház, Győr

Miskolc 3526

Borsod Abauj Zemplén Megyei Kórház, Neurologiai Osztaly, Miskolc

Zalaegerszeg 8900

Zala County Hospital, Department of Cardiology, Zalaegerszeg

Bloemfontein 9301

Quinta-Med, Bloemfontein

West Cape 8001

Chris Barnard Memorial Hospital, Cape Town

KZ-Natal 4001

St. Augustine's Medical Mews, Durban

Gauteng 1619

Francois Le Clus, Johannesburg

Guateng 0157

Dr I Engelbrecht, Lyttleton

Gauteng 0044

Pretoria East Hospital, Neuro-Orthopaedic Unit, Pretoria

Gauteng 0081

Intercare Corporate Office, Pretoria

Gauteng 0082

Dr J Bouwer, Pretoria

Gauteng 0181

Little Company of Mary, Neurospinal Building, Pretoria

Guateng 0002

SCION Clinical Research, 316 Medi-Clinic Heart Hospital, Pretoria

WC1N 3BG

The National Hospital for Neurology & Neurosurgery, London